Lantheus Holdings, Inc.

US$100.61As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:LNTHHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR 27.75%
Div yield —
ROE 21.81%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.03
PE TTM 25.03
TSR TTM 74.40%
Mkt cap US$6.580B
ROIC 15.75%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$102
1.19%
55.49%
Hold 2|10|1|11|6
4Q25
1Q26
2Q26
3Q26
Earnings per share$
1.00
0.98
1.01
1.11
10.18%
(0.23%)
0.08%
6.71%
Revenue$M
391.1
406.2
418.3
438.9
6.07%
8.51%
6.31%
12.85%
Peers (US$6.580B)
Cap (US$)
PE
5.434B
7.363x
Capital
TTM
5Y
10Y
Leveragex
1.674
0.296
0.270
EBIT/Intx
0.581
0.303
0.379
Own earn%
48.50
(70.21)
(64.17)
Sh yield%
53.16
49.49
43.39
Owners
Insiders/Inst%
1.76
43.25
Short interest%
4.31
SBC / revenue%
1.19
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
10
Op margin range%
0–5
$1 testx
—
Incr. ROIC%
1